BridgeBio has significantly advanced this progress of a novel treatment for ATTR-CM, utilizing the compound. Preliminary trial results indicates potential improvements for patients affected with the severe disease. This https://attruby765592.webdesign96.com/42402144/bridgebio-advances-attr-cm-treatment-with-the-therapy